Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues

International Journal of Artificial Organs

Volumn 34, Issue 9, 2011, Pages 771-780

  Arciola, Carla Renata ^a,b   Visai, Livia ^c,d   Testoni, Francesca ^a   Arciola, Susanna ^a,e   Campoccia, Davide ^a   Speziale, Pietro ^c   Montanaro, Lucio ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d International Center for Studies and Research in Biomedicine (ICB)   (Belgium)

^e Ospedale Buonconsiglio Fatebenefratelli   (Italy)

Author keywords

Agr; Biofilm; Implant infection; MSCRAMMs; Staphylococcus aureus; Toxins

Indexed keywords

ADHESION; HISTOLOGY; PROSTHETICS; TISSUE;

AGR; IMPLANT INFECTIONS; MSCRAMM; ORTHOPAEDIC IMPLANTS; S. AUREUS; VIRULENCE FACTORS;

BACTERIA;

ADHESIN; ALPHA HEMOLYSIN; BETA LACTAM; COAGULASE; COLLAGEN; CYTOTOXIN; ELASTIN; FIBRINOGEN; FIBRONECTIN BINDING PROTEIN; HEMOLYSIN; INTERLEUKIN 1; INVASIN; LEUKOCIDIN; PANTON VALENTINE LEUKOCIDIN; PEPTIDOGLYCAN; SCLEROPROTEIN; STAPHYLOCOCCUS ENTEROTOXIN; T LYMPHOCYTE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1; TUMOR NECROSIS FACTOR RECEPTOR 1; VIRULENCE FACTOR; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIGEN PRESENTING CELL; BACTERIAL CELL WALL; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIOFILM; BONE INFECTION; CELL ADHESION; CYTOKINE PRODUCTION; DEGRADATION; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MATURATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOCYTE; NONHUMAN; OSTEOMYELITIS; PHAGOCYTOSIS; POLYMERIZATION; PROSTHESIS; PROSTHESIS INFECTION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TRANSPOSON; TROPISM;

EID: 81355132374     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000046     Document Type: Review

References (99)

1. Ogston A. A Micrococcus poisoning. J Anat. 1882;17:24-58.
2. Alexander EH and Hudson MC. Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl Microbiol Biotechnol. 2001;56:361-366.
3. Jevons MP. "Celbenin"-resistant staphylococci. Br Med J. 1961;1:124-125.
4. Deurenberg RH, Vink C, Kalenic S, Friederich AW, Bruggeman CA, Stobberingh EE. The molecular evolution of methicillin- resistant Staphylococcus aureus. Clin Microbiol Infect. 2007;13(3):222-235.
5. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopaedic devices and issues of antibiotic resistance. Biomaterials 2006;27(11):2331-2339.
6. Campoccia D, Montanaro L, Arciola CR. Current methods for molecular epidemiology studies of implant infections. Int J Artif Organs. 2009;32(9):642-654.
7. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520-532.
8. Arciola CR, An YH, Campoccia D, Donati ME, Montanaro L. Etiology of implant orthopaedic infections: a survey on 1027 clinical isolates. Int J Artif Organs 2005;28(11):1091-1100.
9. Campoccia D, Montanaro L, Visai L, et al. Characterization of 26 Staphylococcus warneri isolates from orthopedic infections. Int J Artif Organs 2010;33(9):575-581.
10. von Eiff C, Arciola CR, Montanaro L, Becker K, Campoccia D. Emerging Staphylococcus species as a new pathogens in implant infections. Int J Artif Organs 2006;29:360-367.
11. Feng Y, Chen CJ, Su LH, Hu S, Yu J, Chiu CH. Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol Rev. 2008;32(1):23-37.
12. Blanc DS, Petignat C, Wenger A, et al. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. J Clin Microbiol. 2007;45(11):3729-3736.
13. Patti JM, Hook M. Microbial adhesions recognizing extracellular matrix macromolecules. Curr Opin Cell Biol. 1994;6(5):752-758.
14. Patti JM, Allen BL, McGavin MJ, Höök M. MSCRAMM-mediated adherence of microorganism to host tissues. Annu Rev Microbiol. 1994a;48:585-617.
15. Speziale P, Pietrocola G, Rindi S, et al. Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol. 2009;4:1337-1352.
16. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46(S5):S350-S359.
17. Navarre W, Schneewind O. Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999;63(1):174-229.
18. Greene C, McDevitt D, Francois P, Vaudaux PE, Lew DP, Foster TJ. Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes. Mol Microbiol. 1995;17(6):1143-1152.
19. Hauck CR, Ohlsen K. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol. 2006;9(1):5-11.
20. Schwarz-Linek U, Werner JM, Pickford AR, et al. Pathogenic bacteria attach to human fibronectin through a tandem betazipper. Nature. 2003;423(6936):177-181.
21. Schwarz-Linek U, Hook M, Potts JR. The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol. 2004;52:631-641.
22. Sinha B, Francois PP, Nüsse O, et al. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol. 1999;1(2):101-117.
23. Sinha B, Francois P, Que YA, et al. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun. 2000;68:6871-6878.
24. Fowler T, Wann ER, Joh D, Johansson S, Foster TJ, Hook M. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol. 2000;79:672-679.
25. Agerer F, Michel A, Ohlsen K, Hauck CR. Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein tyrosine kinases. J Biol Chem. 2003;278:42524-42531.
26. Edwards AM, Potts JR, Josefsson E, Massey RC. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLOS Pathog 2010;6(6):e1000964.
27. Edwards AM, Massey RC. Invasion of human cells by a bacterial pathogen. J Vis Exp. 2011;(49). pii: 2693. DOI: 10.3791/2693.
28. Edwards AM, Potter U, Meenan NA, Potts JR, Massey RC. Staphylococcus aureus keratinocyte invasion is dependent upon multiple high-affinity fibronectin-binding repeats within FnBPA. PLoS One. 2011;6(4):e18899.
29. Shinji H, Yosizawa Y, Tajima A, et al. Role of fibronectin-binding proteins A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus. Infect Immun. 2011;79(6):2215-23.
30. Testoni F, Montanaro L, Campoccia D, Visai L, Arciola CR. Internalization by osteoblasts of two Staphylococcus aureus clinical isolates differing in their adhesin gene pattern. Int J Artif Organs. 2011;34(9): 789-798.
31. Peacock SJ, Day NP, Thomas MG, Berendt AR, Foster TJ. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin. J Infect. 2000;41:23-31.
32. Peacock SJ, Moore CE, Justice A, et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun. 2002;70(9):4987-4996.
33. Patti JM, Boles JO, Höök M. Identification and biochemical characterization of the ligand binding domain of the collagen adhesin from Staphylococcus aureus. Biochemistry. 1993;32(42):11428-11435.
34. Switalski LM, Patti M, Butcher W, Gristina AG, Speziale P, Hook M. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol. 1993;7:99-107.
35. Montanaro L, Arciola CR, Baldassarri L, Borsetti E. Presence and expression of collagen adhesin gene (cna) and slime production in Staphylococcus aureus strains from orthopaedic prosthesis infections. Biomaterials. 1999;20(20):1945-1949.
36. Patti JM, Bremell D, Krajewska-Pietrasik A, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun. 1994b;62:152-161.
37. Elasri MO, Thomas JR, Skinner RA, et al. Staphylococcus aureus collagen adhesion contributes to the pathogenesis of osteomyelitis. Bone. 2002;30(1):275-280.
38. Hienz SA, Schennings T, Heimdahl A, Flock JL. Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis. 1996;174:83-88.
39. Rhem MN, Lech EM, Patti JM, et al. The collagen-binding adhesion is a virulence factor in Staphylococcus aureus keratitis. Infect Immun. 2000;68:3776-3779.
40. Holderbaum D, Spech T, Ehrhart LA, Keys T, Hall GS. Collagen binding in clinical isolates of Staphylococcus aureus. J Clin Microbiol. 1987;25:2258-2261.
41. Ryding U, Flock JI, Flock M, Soderquist B, Christensson B. Expression of collagen-binding protein and type 5 and 8 capsular polysaccharide in clinical isolates of Staphylococcus aureus. J Infect Dis. 1997;176:1096-1099.
42. Thomas MG, Peacock S, Daenke S, Berendt AR. Adhesion of Staphylococcus aureus to collagen is not a major virulence determinant for septic arthritis, osteomyelitis, or endocarditis. J Infect Dis. 1999;179:291-293.
43. Campoccia D, Speziale P, Ravaioli S, et al. The presence of both bone sialoprotein-binding protein gene and collagen adhesin gene as a typical virulence trait of the major epidemic cluster in isolates from orthopedic implant infections. Biomaterials. 2009;30(34):6621-8.
44. Nakakido M, Tanaka Y, Tsumoto K. The N-terminal domain of elastin-binding protein of Staphylococcus aureus changes its secondary structure in a membrane-mimetic environment. J Biochem. 2007;142(2):131-134.
45. Campoccia D, Montanaro L, Ravaioli S, Cangini I, Speziale P, Arciola CR. Description of a new group of variants of the Staphylococcus aureus elastin-binding protein that lacks an entire DNA segment of 180 bp. Int J Artif Organs. 2009;32(9):621-629.
46. Sabat A, Melles DC, Martirosian G, Grundmann H, van Belkum A, Hryniewicz W. Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J Clin Microbiol. 2006;44(3):1135-1138.
47. Tung H, Guss B, Hellman U, Persson L, Rubin K, Rydén C. A bone sialoproteina-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J. 2000;345(Pt 3):611-619.
48. Persson L, Johansson C, Rydén C. Antibodies to Staphylococcus aureus bone sialoprotein-binding protein indicate infectious osteomyelitis. Clin Vaccine Immunol. 2009;16(6):949-952.
49. Josefsson E, McCrea KW, Nì Eidhin D, et al. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology. 1998;144(Pt 12):3387-3395.
50. Trad S, Allignet J, Franguel L, et al. DNA macroarray for identification and typing of Staphylococcus aureus isolates. J Clin Microbiol. 2004;42(5):2054-2064.
51. Heilmann C, Schweitzer O, Gerke C, et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol. 1996;20:1083-1091.
52. Gerke C, Kraft A, Sussmuth R, et al. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem. 1998;273:18586-18593.
53. Cramton, SE, Gerke C, Schnell NF, et al. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 1999;67:5427-5433.
54. Arciola CR, Baldassarri I, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol. 2001;39:2151-2156.
55. Arciola CR, Baldassarri L, Montanaro L. In catheter infections by Staphylococcus epidermidis the intercellular adhesion (ica) locus is a molecular marker of the virulent slimeproducing strains. J Biomed Mater Res. 2002;59(3):557-562.
56. Whitchurch CB, Tolker-Nielsen T, Ragas PC, et al. Extracellular DNA required for bacterial biofilm formation. Science. 2002;295:1487.
57. Allesen-Holm M, Barken KB, Yang L, et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol. 2006;59:1114-1128.
58. Thomas VC, Hancock LE. Suicide and fratricide in bacterial biofilms. Int J Artif Organs. 2009;32(9):537-544. Review
59. Arciola CR, Visai L, Ravaioli S, Cangini I, Campoccia D, Montanaro L. Extracellular DNA in biofilms. Int J Artif Organs. 2011;34(9): 824-831.
60. Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect. 2001;49(2):87-93. Review.
61. Beech IB, Sunner J, Arciola CR, Cristiani P. Microbially influenced corrosion: damage to prostheses, delight for bacteria. Int J Artif Organs. 2006;29(4):443-452.
62. Bone RC. Gram-positive organisms and sepsis. Arch Int Med. 1994;154:26-34.
63. O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev. 2004;17(1):218-234.
64. Cedergren L, Andersson R, Jansson B, Uhlen M, Nilsson B. Mutational analysis of the interaction between staphylococcal protein A and human IgG1. Protein Eng. 1993;6:441-448.
65. Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis. 2008;198(1):125-133.
66. O'Seaghdha M, van Schooten CJ, Kerrigan SW, et al. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain in mediated by conserved IgG binding regions. FEBS J 2006;273:4831-4841.
67. Gomez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem. 2006;281:20190-20196.
68. Claro T, Widaa A, O'Seaghdha M, et al. Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PloS One. 2011;6(4):e18748.
69. Jongerius I, Köhl J, Pandey MK, et al. Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med. 2007;204(10):2461-2471.
70. Kaneko J, Kamio Y. Bacterial two-component and heteroheptameric pore-forming cytolytic toxins: structures, poreforming mechanism, and organization of the genes. Biosci Biotechnol Biochem. 2004;68:981-1003.
71. Menestrina G, Serra MD, Prevost G. Mode of action of Betabarrel pore-forming toxins of the staphylococcal alfa-hemolysin family. Toxicon. 2001;39:1661-1672.
72. Vandenesch F, Naimi T, Enrigh MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9(8):978-984.
73. Montanaro L, Baldassarri L, Corazzari T, et al. Panton-Valentine leukocidin gene detected in Staphylococcus aureus strain isolated from a knee arthroprosthesis infection. Int J Artif Organs. 2009;32(9):630-634.
74. Campoccia D, Baldassarri L, Pirini V, Ravaioli S, Montanaro L, Arciola CR. Molecular epidemiology of Staphylococcus aureus from implant orthopaedic infections: Ribotypes, agr polymorphism, leucocidal toxins and antibiotic resistance. Biomaterials. 2008;29:4108-4116.
75. Larkin EA, Carman RJ, Krakauer T, Stiles BG. Staphylococcus aureus: the toxic presence of a pathogen extraordinaire. Curr Med Chem. 2009;16(30):4003-4019.
76. Le Loir Y, Baron F, Gautier M. Staphylococcus aureus and food poisoning. Genet Mol Res. 2003;2:63-76.
77. Cunningham R, Cockayne A, Humphreys H. Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol. 1996;44:157-164.
78. Makris G, Wright JD, Ingham E, Holland KT. The hyaluronate lyase of Staphylococcus aureus-a virulence factor? Microbiology. 2004;150(Pt 6):2005-2013.
79. Costerton JW, Montanaro L, Arciola CR. Bacterial communications in implant infections: a target for an intelligence war. Int J Artif Organs. 2007;30(9):757-763. Review.
80. Sørensen SJ, Bailey M, Hansen LH, et al. Studying plasmid horizontal transfer in situ: a critical review, Nat Rev Microbiol. 2005;3:700-710.
81. Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents. 2000;16(S1):3-10.
82. Arciola CR, Campoccia D, Gamberini S, et al. Search for the insertion element IS256 within the ica locus of Staphylococcus epidermidis clinical isolates collected from biomaterialassociated infections. Biomaterials. 2004;25:4117-4125.
83. Montanaro L, Campoccia D, Pirini V, et al. Antibiotic mul tiresistance strictly associated with IS256 and ica genes in Staphylococcus epidermidis strains from implant orthopedic infections, J Biomed Mater Res A. 2007;83: 813-818.
84. Campoccia D, Montanaro L, Pirini V, et al. Prevalence of genes for aminoglycoside-modifying enzymes in Staphylococcus epidermidis isolates from orthopedic postsurgical and implant-related infections. J Biomed Mater Res A. 2009;88:654-663.
85. Lyon BR, Skurray R. Antimicrobial resistance of Staphylococcus aureus: Genetic basis. Microbiol Rev. 1987;51:88-134.
86. Molin S, Tolker-Nielsen T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol. 2003;14:255-261.
87. Foster TJ. Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion. Vet Dermatol. 2009;20(5-6):456-470.
88. Dubin G. Extracellular proteases of Staphylococcus spp. Biol Chem. 2001;383(7-8):1075-1086.
89. Otto M. Basis of virulence in community-associated methicillin- resistant Staphylococcus aureus. Annu Rev Microbiol. 2010;64:143-162.
90. Montanaro L, Campoccia D, Arciola CR. Advancements in molecular epidemiology of implant infections and future perspectives. Biomaterials. 2007;28:5155-5168.
91. Arciola CR, Campoccia D, Baldassarri L, et al. Detection of biofilm formation in Staphylococcus epidermidis from implant infections. Comparison of a PCR-method that recognizes the presence of ica genes with two classic phenotypic methods. J Biomed Mater Res A. 2006; 76 (2): 425-30.
92. Costerton WJ, Montanaro L, Balaban N, Arciola CR. Prospecting gene therapy of implant infections. Int J Artif Organs. 2009;32(9):689-695. Review.
93. Bruellhoff K, Fiedler J, Möller M, Groll J, Brenner RE. Surface coating strategies to prevent biofilm formation on implant surfaces. Int J Artif Organs. 2010;33(9):646-653. Review.
94. Groll J, Fiedler J, Bruellhoff K, Moeller M, Brenner RE. Novel surface coatings modulating eukaryotic cell adhesion and preventing implant infection. Int J Artif Organs. 2009;32(9): 655-662. Review.
95. Arciola CR. New concepts and new weapons in implant infections. Int J Artif Organs. 2009;32:533-536.
96. JB. Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs. 2009;32(9):545-554. Review.
97. Campoccia D, Arciola CR, Cervellati M, et al. In vitro behaviour of bone marrow-derived mesenchymal cells cultured on fluorohydroxyapatite-coated substrata with different roughness. Biomaterials. 2003;24(4):587-596.
98. Arciola CR, Montanaro L, Giordano M, et al. Hydroxyapatitecoated orthopaedic screws as infection resistant materials: In vitro study. Biomaterials. 1999;20(4):323-7.
99. Petrini P, Arciola CR, Pezzali I, et al. Antibacterial activity of zinc modified titanium oxide surface. Int J Artif Organs. 2006;29:434-442.